Avoro Capital Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,111,111	Closed	-$262M	–	50
2023 Q4	$262M	Buy	11,111,111 +811,111	+8%	+$19.2M	3.63%	13
2023 Q3	$154M	Hold	10,300,000	–	–	2.4%	15
2023 Q2	$113M	Hold	10,300,000	–	–	1.53%	16
2023 Q1	$89.8M	Hold	10,300,000	–	–	1.33%	18
2022 Q4	$64.6M	Hold	10,300,000	–	–	0.97%	20
2022 Q3	$36.1M	Hold	10,300,000	–	–	0.67%	25
2022 Q2	$30.4M	Hold	10,300,000	–	–	0.6%	27
2022 Q1	$32M	Hold	10,300,000	–	–	0.58%	26
2021 Q4	$34.8M	Hold	10,300,000	–	–	0.59%	28
2021 Q3	$37.6M	Hold	10,300,000	–	–	0.59%	25
2021 Q2	$44.9M	Hold	10,300,000	–	–	0.78%	27
2021 Q1	$46.8M	Hold	10,300,000	–	–	0.81%	26
2020 Q4	$59.1M	Hold	10,300,000	–	–	1.02%	22
2020 Q3	$74.6M	Buy	10,300,000 +5,050,000	+96%	+$36.6M	1.06%	22
2020 Q2	$18.3M	Sell	5,250,000 -250,000	-5%	-$873K	0.36%	34
2020 Q1	$8.14M	Hold	5,500,000	–	–	0.27%	34
2019 Q4	$10.8M	Buy	5,500,000 +2,800,000	+104%	+$5.49M	0.32%	27
2019 Q3	$13.8M	Hold	2,700,000	–	–	0.58%	27
2019 Q2	$19.3M	Buy	2,700,000 +1,975,000	+272%	+$14.1M	0.67%	25
2019 Q1	$9.63M	Buy	+725,000	New	+$9.63M	0.42%	26
2018 Q3	–	Sell	-1,282,374	Closed	-$17.2M	–	49
2018 Q2	$17.2M	Buy	+1,282,374	New	+$17.2M	0.66%	27